Total Payments
$5,585
2024 Payments
$49.47
Companies
13
Transactions
34
Medicare Patients
4,086
Medicare Billing
$214,025
Payment Breakdown by Category
Consulting$2,538 (45.4%)
Travel$1,834 (32.8%)
Food & Beverage$763.45 (13.7%)
Other$450.00 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,538 | 2 | 45.4% |
| Travel and Lodging | $1,834 | 6 | 32.8% |
| Food and Beverage | $763.45 | 24 | 13.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450.00 | 2 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,745 | 17 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $350.00 | 1 | $0 (2021) |
| Johnson & Johnson Vision Care, Inc. | $113.76 | 2 | $0 (2020) |
| United Therapeutics Corporation | $100.00 | 1 | $0 (2018) |
| CSL Behring | $66.90 | 3 | $0 (2020) |
| Abbott Laboratories | $45.01 | 2 | $0 (2024) |
| Novo Nordisk Inc | $41.88 | 2 | $0 (2018) |
| Aveo Pharmaceuticals, Inc. | $26.64 | 1 | $0 (2024) |
| Coherus Biosciences Inc. | $22.24 | 1 | $0 (2021) |
| Mirati Therapeutics, Inc. | $21.12 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.47 | 2 | Aveo Pharmaceuticals, Inc. ($26.64) |
| 2023 | $1,938 | 10 | ABBVIE INC. ($1,875) |
| 2022 | $17.23 | 1 | E.R. Squibb & Sons, L.L.C. ($17.23) |
| 2021 | $372.24 | 2 | SANOFI-AVENTIS U.S. LLC ($350.00) |
| 2020 | $137.35 | 3 | Johnson & Johnson Vision Care, Inc. ($113.76) |
| 2019 | $43.31 | 2 | CSL Behring ($43.31) |
| 2018 | $594.08 | 5 | AbbVie, Inc. ($437.50) |
| 2017 | $2,433 | 9 | AbbVie, Inc. ($2,433) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/01/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/15/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: HEMATOLOGY | ||||||
| 11/17/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2023 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $896.21 | General |
| 10/06/2023 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $200.00 | General |
| 10/06/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $82.76 | General |
| 10/06/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $37.51 | General |
| 10/05/2023 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $351.03 | General |
| 10/05/2023 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $200.00 | General |
| 10/05/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $107.20 | General |
| 09/15/2023 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/25/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Oncology | ||||||
| 12/01/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 03/29/2021 | SANOFI-AVENTIS U.S. LLC | LEMTRADA (Biological), THYMOGLOBULIN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Neurology | ||||||
| 03/05/2020 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $96.44 | General |
| Category: Soft Contact Lenses | ||||||
| 03/05/2020 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Soft Contact Lenses | ||||||
| 02/05/2020 | CSL Behring | Idelvion (Biological) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Hematology | ||||||
| 05/01/2019 | CSL Behring | Idelvion (Biological) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Hematology | ||||||
| 01/02/2019 | CSL Behring | Idelvion (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Hematology | ||||||
| 11/16/2018 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $437.50 | General |
| 11/12/2018 | United Therapeutics Corporation | UNITUXIN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $100.00 | General |
| Category: UNITUXIN | ||||||
| 07/18/2018 | Novo Nordisk Inc | REBINYN (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Hemophilia | ||||||
| 06/06/2018 | Bayer HealthCare Pharmaceuticals Inc. | Kovaltry (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Hematology | ||||||
| 03/21/2018 | Novo Nordisk Inc | NovoSeven RT (Drug), Novoeight, Tretten | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Hemophilia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 874 | 1,371 | $234,736 | $42,059 |
| 2022 | 21 | 1,180 | 1,888 | $319,180 | $59,349 |
| 2021 | 22 | 1,003 | 1,606 | $262,589 | $50,536 |
| 2020 | 22 | 1,029 | 1,786 | $300,830 | $62,081 |
Total Patients
4,086
Total Services
6,651
Medicare Billing
$214,025
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 204 | 405 | $70,875 | $11,086 | 15.6% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 57 | 109 | $25,615 | $5,642 | 22.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 40 | 73 | $19,710 | $4,566 | 23.2% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 48 | 49 | $15,141 | $3,084 | 20.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 58 | 138 | $7,314 | $2,965 | 40.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 72 | 86 | $12,556 | $2,279 | 18.1% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2023 | 100 | 120 | $15,000 | $1,935 | 12.9% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 72 | 80 | $15,200 | $1,656 | 10.9% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 19 | 48 | $8,064 | $1,293 | 16.0% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 14 | 33 | $7,491 | $1,048 | 14.0% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 13 | 22 | $5,258 | $1,035 | 19.7% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 17 | 21 | $5,019 | $941.57 | 18.8% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 16 | 16 | $7,184 | $924.62 | 12.9% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2023 | 15 | 19 | $6,460 | $832.22 | 12.9% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 19 | 21 | $4,830 | $776.37 | 16.1% |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | Facility | 2023 | 23 | 24 | $2,040 | $515.04 | 25.2% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Facility | 2023 | 13 | 28 | $1,456 | $461.62 | 31.7% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 23 | 23 | $1,495 | $418.21 | 28.0% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 24 | 28 | $1,848 | $264.30 | 14.3% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2023 | 15 | 15 | $750.00 | $223.95 | 29.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 12 | 13 | $1,430 | $112.34 | 7.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 259 | 511 | $89,425 | $14,597 | 16.3% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 74 | 126 | $29,610 | $6,739 | 22.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 83 | 308 | $16,324 | $6,681 | 40.9% |
| 88325 | Surgical pathology consultation and report, comprehensive | Facility | 2022 | 41 | 42 | $20,202 | $4,245 | 21.0% |
About Dr. Nikhil Patel, M.D
Dr. Nikhil Patel, M.D is a Clinical Pathology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1659505220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nikhil Patel, M.D has received a total of $5,585 in payments from pharmaceutical and medical device companies, with $49.47 received in 2024. These payments were reported across 34 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($2,538).
As a Medicare-enrolled provider, Patel has provided services to 4,086 Medicare beneficiaries, totaling 6,651 services with total Medicare billing of $214,025. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Pathology
- Location Augusta, GA
- Active Since 05/11/2009
- Last Updated 08/26/2015
- Taxonomy Code 207ZC0006X
- Entity Type Individual
- NPI Number 1659505220
Products in Payments
- LEMTRADA (Biological) $350.00
- Acuvue (Device) $113.76
- UNITUXIN (Drug) $100.00
- Idelvion (Biological) $66.90
- FOTIVDA (Drug) $26.64
- REBINYN (Drug) $23.38
- AVEIR (Device) $22.83
- Udenyca (Biological) $22.24
- MERLIN@HOME (Device) $22.18
- KRAZATI (Drug) $21.12
- MONOFERRIC (Drug) $19.99
- NovoSeven RT (Drug) $18.50
- OPDIVO (Biological) $17.23
- Kovaltry (Drug) $14.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.